In plain language
In a phantom study of videofluoroscopic swallowing studies, measured eye dose was highest for the 150-cm staff phantom, more than twice the taller phantoms. Lead glasses reduced patient-phantom eye dose 92-93% frontally but less consistently laterally. These are dose measurements, not health outcomes.
At a glance
- Type of study
- Original research, Phantom or simulation study
- Who was studied
- Phantom or simulation (no people), Patients, Mixed lab staff
- Summary based on
- the abstract
What it found
During a 10-minute VFSS, eye dose was highest for the shortest (150 cm) staff phantom, well above the 165 cm and 180 cm phantoms.
Key figures: 0.097 mGy (150 cm) vs 0.043 mGy (165 cm) and 0.038 mGy (180 cm); increase of 77.1% and 87.4%
Lead-equivalent glasses protected the patient phantom's eyes well in the AP position but less, and more variably, in the lateral position.
Key figures: 92.0-93.4% (AP) vs 15.8-83.2% (lateral)
Without glasses, patient eye dose was higher in the AP position than in the lateral position.
Key figures: 36.5 mGy (AP) vs 14.5 mGy (lateral)
Authors conclude that shorter staff need particular attention to eye protection.
Limits to keep in mind
Phantom measurements in a simulated 10-minute procedure, so results reflect dose geometry rather than real staff exposure or health outcomes. The abstract does not report staff-specific glasses efficiency, the number of measurements, or the country.
Related research summaries
- Radiation protection practices in diagnostic and interventional cardiology: Position paper from Portuguese Association of Interventional Cardiology (2025, Guideline or consensus statement)
- Radiation Protection in Interventional Radiology (2022, Narrative review)
- NCRP Commentary 26 - Guidance on Radiation Dose Limits for Lens of Eye (2016, Guideline or consensus statement)
- Dosimetry During Percutaneous Coronary Interventions Of Chronic Total Occlusions (2018, Dosimetry measurement study)
- Radiation Exposure of Patients and Interventional Radiologists during Prostatic Artery Embolization: A Prospective Single-Operator Study (2017, Dosimetry measurement study)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.